Article
Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
Anti-cancer drugs - 1 Oct 2005
Candelaria Myrna, Taja-Chayeb Lucia, Arce-Salinas Claudia, Vidal-Millan Silvia, Serrano-Olvera Alberto, Dueñas-Gonzalez Alfonso
Abstract excerpt
Drug-metabolizing enzymes are responsible for the activation or detoxification of cytotoxic drugs. Allelic variants are present with a variable frequency in different populations around the world and have an important role in the therapeutic index of such drugs. It is known that polymorphisms in thiopurine methyltransferase and dihydropyrimidine dehydrogenase have been associated with altered drug metabolism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
